asa guidelines for glp-1 drugs How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies Anesthetic Management of Patients on Glucagon-Like Anesthetic Considerations for Patients Taking

The NEJM authors reported the most common side effects as mild-to-moderate gastrointestinal events, with the trial discontinued due to adverse events in 4.4% to 7.8% of participants receiving orforglipron compared to 1.4% given the placebo

Bile acid Bile acids (BAs) play an important role in controlling the body's glucose response after a meal by stimulating GLP-1 secretion

The impact of chronic kidney disease (CKD) in type 2 diabetes extends beyond renal dysfunction, encompassing a spectrum of systemic complications and comorbidities

Follow label directions or guidance from your healthcare professional

These conversations should address several key areas to optimize both RA management and overall health